New hope for leukemia patients: targeted therapy aims to wipe out hidden cancer cells
NCT ID NCT03737955
First seen Jan 29, 2026 · Last updated May 05, 2026 · Updated 10 times
Summary
This study tests a targeted drug called gemtuzumab ozogamicin in adults with acute myeloid leukemia who are in remission but still have small amounts of cancer cells (measurable residual disease). The drug works like a smart bomb, attaching to a protein on leukemia cells and delivering chemotherapy directly to them. The goal is to clear these hidden cells and improve long-term outcomes. About 36 participants will receive up to two cycles of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fred Hutchinson Cancer Center/University of Washington Cancer Consortium
RECRUITINGSeattle, Washington, 98109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.